Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor-Reference-Cited by-同舟云学术

Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor

Published:2006 Issue:8 Volume:107 Page:1898-1908
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Trent Jonathan C.,Ramdas Latha,Dupart Jheri,Hunt Kelly,Macapinlac Homer,Taylor Ellen,Hu Limei,Salvado August,Abbruzzese James L.,Pollock Raphael,Benjamin Robert S.,Zhang Wei

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach

2. Two Hundred Gastrointestinal Stromal Tumors

3. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

4. A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas

5. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET imaging of Gastrointestinal Stromal Tumors (GIST);Nuclear Medicine and Molecular Imaging;2022

2. GEIS guidelines for gastrointestinal sarcomas (GIST);Cancer Treatment Reviews;2017-04

3. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers;Tumor Biology;2015-09-14

4. Therapeutic targets in gastrointestinal stromal tumors;World Journal of Translational Medicine;2015

5. GEIS 2013 guidelines for gastrointestinal sarcomas (GIST);Cancer Chemotherapy and Pharmacology;2014-09-06